Berry van Wijk
Europe Guide 2024
Band 1 : Insurance
Email address
[email protected]Contact number
(+31 10 217 24 29)Share profile
About
Provided by Berry van Wijk
Practice Areas
Berry van Wijk is a financial regulatory expert and leads Houthoff's Financial Regulatory Team. The team advises the financial industry on all possible regulatory issues while Berry focuses on the insurance industry and financial service providers.
She assists her clients in their contact with the Dutch regulators, the Dutch Central Bank (DNB) and the Netherlands Authority for the Financial Markets (AFM), and in the implementation of regulatory legal requirements and development of new product and distribution channels. Berry also advises on the regulatory components of M&A transactions in the financial services industry.
Her expertise further lies in unit-linked insurance; she currently represents Nationale Nederlanden in a class action.
She is a trusted adviser to board members and in-house counsel of several insurance companies. Berry is a daily board member of the Association for Insurance Sciences (Vereniging voor Verzekeringswetenschap) and president of the Advisory Committee on Insurance of the Dutch Bar Association (Orde van Advocaten). She is also a member of the Supervisory Board of the Albert Schweitzer hospital and of the Supervisory Board of Luxor Theatre Rotterdam. Berry is a member of Houthoff's Supervisory Board.
Berry is a lecturer on several post-academic programmes, such as the Insurance Law course (Leergang Verzekeringsrecht) at the Univerity of Amsterdam. She also lectures for theCo-Insurance course (Leergang Co-Assurantie) and the master's programme in Insurance Law at Erasmus University. She is a member of the editorial team of the online Tijdschrift Verzekeringsrecht, Aansprakelijkheid, Schade en Toezicht (VAST), formerly known as the Tijdschrift Aansprakelijkheids- en Verzekeringsrecht in de Praktijk (TAV).
Chambers Review
Europe
Berry van Wijk has considerable experience defending insurers in class actions. She is particularly noted for her breadth of knowledge on regulatory matters, such as the launch of new products and obtaining regulatory approval for transactions and portfolio transfers.